Galderma tests Europe's nascent IPO recovery with Sfr2.1bn flotation

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

Cookies Settings
Equity
Equity IPOs

Galderma tests Europe's nascent IPO recovery with Sfr2.1bn flotation

Gaia Freydefont
March 06, 2024 05:23 pm
galderma.jpg

Long delayed listing of Nestlé's former skincare division is finally underway

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

Equity IPOsEquitySwitzerlandHealth and Biotech
GF
Gaia Freydefont
Equities, People & Markets Reporter GlobalCapital
Contact
Gift this article